IP Library Granted Patent US 10,463,857
Granted Patent B2
US 10,463,857 · App. 14/522,500 · Granted Nov 5, 2019

Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods

Inventors: Konstantinos Alataris (Belmont, CA); Andre B. Walker (Monte Sereno, CA); Jon Parker (San Jose, CA); Yougandh Chitre (Santa Clara, CA); Sangsoo Wesley Park (San Jose, CA); James R. Thacker (Homer, AK)
Assignee: Nevro Corp.
A61N1/36071A61N1/0551A61N1/0553A61N1/06A61N1/36021A61N1/36157A61N1/36164A61N1/36167A61N1/36171A61N1/36175A61N1/36182A61N1/3787A61N1/37235A61N1/37241A61N1/37247A61N1/37264A61N1/3605
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,463,857
App. No.
14/522,500
Granted
Nov 5, 2019
Kind
B2
Abstract

A spinal cord modulation system is disclosed. While in one embodiment the system is used for the treatment of pain, other embodiments are also provided. In particular embodiments, the spinal cord modulation system generates and delivers an electrical therapy signal at a frequency in the range of from about 5 kHz to about 15 kHz to address pain without creating unwanted sensory and/or motor side effects. The system may further include various signal delivery devices to deliver the therapy signal to a patient's spinal cord region.

Claims (64)

1. A spinal cord modulation system, comprising:

at least one machine-readable memory containing therapy signal parameters, including:

(i) a frequency in a frequency range from 1.5 kHz to 10 kHz,

(ii) an amplitude between 0.5 mA and 4 mA, and

(iii) pulse widths between 30 microseconds and 35 microseconds;

a signal generator for generating a therapy signal in accordance with the therapy signal parameters; and

an implantable signal delivery device implantable in a patient's epidural space and operatively coupleable to the signal generator to deliver the therapy signal from the signal generator to the patient's spinal cord.

2. The system of claim 1 , wherein the amplitude is between 2 mA and 3.5 mA.

3. The system of claim 1 , wherein the pulses are square wave pulses.

4. The system of claim 1 , wherein the therapy signal parameters include a duty cycle.

5. The system of claim 4 , wherein the duty cycle is from 50% to 100%.

6. The system of claim 4 , wherein the duty cycle is 70%.

7. The system of claim 4 , wherein the duty cycle is other than 50% to 100%.

8. The system of claim 1 , wherein the signal delivery device is a percutaneous lead.

9. The system of claim 1 , wherein the signal delivery device is a paddle lead.

10. The system of claim 1 , further comprising:

a programmer in wireless communication with the signal generator and having a programmer machine-readable memory containing instructions that, when executed, allow a practitioner and/or a patient to select the amplitude of the therapy signal.

11. A spinal cord modulation system, comprising:

a machine-readable memory containing therapy signal parameters, including:

(i) a frequency in a frequency range from 1.5 kHz to 10 kHz,

(ii) an amplitude between 0.5 mA and 4 mA, and

(iii) pulse widths between 30 microseconds and 35 microseconds;

an implantable signal generator for generating a therapy signal in accordance with the therapy signal parameters; and

an implantable signal delivery device implantable in a patient's epidural space and coupleable to the implantable signal generator to deliver the therapy signal from the implantable signal generator to the patient's spinal cord.

12. The system of claim 11 , wherein the current amplitude is 2.5 mA.

13. The system of claim 11 , wherein the therapy signal includes a plurality of biphasic pulses.

14. The system of claim 13 , wherein the pulses are square wave pulses.

15. The system of claim 11 , wherein the therapy signal parameters include a duty cycle.

16. The system of claim 15 , wherein the duty cycle is from 50% to 100%.

17. The system of claim 15 , wherein the duty cycle is 70%.

18. The system of claim 15 , wherein the duty cycle is other than 50% to 100%.

19. The system of claim 11 , wherein the implantable signal delivery device is a percutaneous lead.

20. The system of claim 11 , wherein the implantable signal delivery device is a paddle lead.

21. A spinal cord modulation system, comprising:

a machine-readable memory containing therapy signal parameters, including:

(i) a frequency in a frequency range from 1.5 kHz to 10 kHz,

(ii) an amplitude between 0.5 mA and 4 mA, and

(iii) pulse widths between 30 microseconds and 35 microseconds;

a signal generator for generating a therapy signal in accordance with the therapy signal parameters;

an implantable signal delivery device implantable in a patient's epidural space and operatively coupleable to the signal generator to deliver the therapy signal to the patient's spinal cord; and

a programmer wirelessly coupleable to the signal generator to communicate instructions to the signal generator.

22. The system of claim 21 , wherein the amplitude is between 2 mA and 3.5 mA.

23. The system of claim 21 , wherein the machine-readable memory is carried by the signal generator and includes instructions that, when executed, (i) generate the therapy signal in accordance with input received from the programmer, and (ii) deliver the therapy signal to the patient's spinal cord via the implantable signal delivery device.

24. A spinal cord modulation system, comprising:

a machine-readable memory containing therapy signal parameters, including:

(i) a frequency in a frequency range from 1.5 kHz to 10 kHz,

(ii) an amplitude between 0.5 mA and 4 mA, and

(iii) pulse widths between 30 microseconds and 35 microseconds;

an implantable signal generator for generating a therapy signal in accordance with the therapy signal parameters;

an implantable signal delivery device implantable in a patient's epidural space and coupleable to the implantable signal generator to deliver the therapy signal from the implantable signal generator to the patient's spinal cord; and

a programmer wirelessly coupleable to the implantable signal generator.

25. The system of claim 24 , wherein the current amplitude is between 2 mA and 3.5 mA.

26. A spinal cord modulation system, comprising:

a machine-readable memory containing therapy signal parameters, including:

(i) a frequency in a frequency range from 1.5 kHz to 10 kHz,

(ii) an amplitude between 0.5 mA and 4 mA, and

(iii) pulse widths between 30 microseconds and 35 microseconds;

a signal generator for generating a therapy signal having a plurality of biphasic pulses in accordance with the therapy signal parameters; and

an implantable delivery device implantable in a patient's epidural space and operatively coupleable to the signal generator to deliver the therapy signal from the signal generator to the patient's spinal cord.

27. The system of claim 26 , wherein the amplitude is between 2 mA and 3.5 mA.

28. The system of claim 26 , wherein the implantable signal delivery device is a percutaneous lead.

29. The system of claim 26 , wherein the implantable signal delivery device is a paddle lead.

30. The system of claim 26 , further comprising:

a programmer in wireless communication with the signal generator and having a programmer machine-readable memory containing instructions that, when executed, allow a practitioner and/or a patient to select the amplitude of the therapy signal.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA PREVIOUSLY RECORDED AT REEL: 034023 FRAME: 0672. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 22, 2016
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORP.
Reel/Frame 040671/0131 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT AGREEMENT (REAFFIRMATION) Recorded Jun 13, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC,
Reel/Frame 038984/0865 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2014
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORPORATION
Reel/Frame 034023/0672 →
Continuity (5)
Continuation 14164100 · Jan 24, 2014
Continuation 12765747 · Apr 22, 2010
Provisional Application 61176868 · May 8, 2009
Provisional Application 61171790 · Apr 22, 2009
Related Publication 20150051664A1 · Feb 19, 2015
Cited By (1)
US 12,465,776